Platelet-rich plasma vs placebo for hair loss in Black women
Treatments studied
Part of Skin clinical trials.
This trial compares platelet-rich plasma (a treatment made from your own blood) to a placebo to see if it helps regrow hair in women with a specific type of scarring hair loss called central centrifugal cicatricial alopecia (CCCA), which often affects women of African descent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You identify as being of African descent (African, Afro-Caribbean, Afro-Latino, or African American).
- You have mild to moderate CCCA hair loss on the top or crown of your scalp, stages 1B, 2B, or 3B.
- You haven't used certain hair loss treatments (like minoxidil or retinoic acid) or anti-inflammatory drugs (like steroids) in the past 4 weeks.
- You are not pregnant and are willing to avoid tight hairstyles that pull on your hair during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests whether platelet-rich plasma (PRP) injections can improve androgenic alopecia, a common pattern of hair thinning. It may help by supporting hair growth, but you must meet safety rules—especially around pregnancy, bleeding risks, and infections or skin conditions.
This trial compares two treatments—secretome and platelet-rich plasma (PRP)—to see which helps grow thicker, denser hair in people with genetic hair loss (androgenetic alopecia). It's for adults aged 25 to 59 who have stopped taking certain hair loss medications for at least a month.
This study compares two types of platelet-rich plasma (PRP) injections — one is standard PRP, the other is PRP that is 'light-enhanced' with special light exposure — to see which works better for treating hair loss due to male or female pattern baldness. If you're struggling with thinning hair, this trial may help you find a more effective non-surgical option.
This trial tests whether combining platelet-rich plasma (PRP) injections with botulinum toxin type A (Botox) can help regrow hair in people with male or female pattern baldness. It aims to see if this combination is safe and effective for treating androgenetic alopecia.
This study looks at treatment results for central centrifugal cicatricial alopecia (CCCA), a type of hair loss that causes scarring and permanent hair loss. It will follow African-American women to see how well treatments work for different levels of severity.
This study compares two treatments for male pattern hair loss: a special injection made from your own fat cells (called stromal vascular fraction) versus a platelet-rich plasma (PRP) injection. Both are designed to help regrow hair.
Hear when a new Central Centrifugal Cicatricial Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.